Prudential Financial Inc Intra Cellular Therapies, Inc. Transaction History

Prudential Financial Inc

  • $70.8 Billion
  • Q4 2024

A detailed history of Prudential Financial Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 4,290 shares of ITCI stock, worth $564,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,290
Previous 26,483 83.8%
Holding current value
$564,950
Previous $1.94 Million 81.51%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$71.19 - $91.57 $1.58 Million - $2.03 Million
-22,193 Reduced 83.8%
4,290 $358,000
Q3 2024

Nov 13, 2024
SELL
$67.99 - $80.84 $6.43 Million - $7.64 Million
-94,518 Reduced 78.11%
26,483 $1.94 Million
Q2 2024

Aug 13, 2024
SELL
$64.76 - $79.84 $2.9 Million - $3.58 Million
-44,827 Reduced 27.03%
121,001 $8.29 Million
Q1 2024

May 14, 2024
BUY
$64.37 - $75.65 $5.4 Million - $6.34 Million
83,817 Added 102.2%
165,828 $11.5 Million
Q4 2023

Feb 13, 2024
BUY
$46.37 - $73.65 $2.55 Million - $4.04 Million
54,917 Added 202.69%
82,011 $5.87 Million
Q3 2023

Nov 13, 2023
SELL
$52.09 - $64.1 $4.06 Million - $5 Million
-77,940 Reduced 74.2%
27,094 $1.41 Million
Q2 2023

Aug 11, 2023
BUY
$54.67 - $66.44 $771,011 - $937,003
14,103 Added 15.51%
105,034 $6.65 Million
Q1 2023

May 12, 2023
BUY
$43.8 - $56.99 $965,395 - $1.26 Million
22,041 Added 31.99%
90,931 $4.92 Million
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $1.64 Million - $2.02 Million
37,108 Added 116.76%
68,890 $0
Q3 2022

Nov 04, 2022
SELL
$42.7 - $59.99 $10.8 Million - $15.2 Million
-253,783 Reduced 88.87%
31,782 $1.48 Million
Q2 2022

Aug 15, 2022
BUY
$43.0 - $65.64 $84,581 - $129,113
1,967 Added 0.69%
285,565 $16.3 Million
Q1 2022

May 13, 2022
BUY
$38.74 - $62.09 $6.49 Million - $10.4 Million
167,433 Added 144.13%
283,598 $17.4 Million
Q4 2021

Feb 14, 2022
BUY
$35.2 - $53.42 $1.37 Million - $2.08 Million
38,872 Added 50.29%
116,165 $6.08 Million
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $650,393 - $962,228
22,646 Added 41.44%
77,293 $2.88 Million
Q2 2021

Aug 16, 2021
BUY
$29.3 - $44.5 $1.6 Million - $2.43 Million
54,647 New
54,647 $2.23 Million

Others Institutions Holding ITCI

# of Institutions
418
Shares Held
87.7M
Call Options Held
284K
Put Options Held
105K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.4B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email